
Rosetrees Trust Interdisciplinary Prize awarded to Hebrew U scientists Yaakov Nahmias and Nir Friedman
Sept 18, 2017 – The Rosetrees Trust Interdisciplinary Prize for 2017 has been awarded to two scientists from the Hebrew University of Jerusalem, Prof. Yaakov Nahmias

JLM-based BreathVision’s Breath Volume Monitoring keeps Patients Safe in the Operating Room
Going under sedation for an operation can sometimes be riskier than the surgical procedure itself. It’s not a problem with the anesthetic. Rather, “drug-induced respiratory depression

Medtronic to open development centers in Jerusalem & Yokneam in cooperation with the Israel Innovation Authority
Sept 11, 2017 – Medical equipment company Medtronic will be the first company to establish development centers in Israel in cooperation with the Israel Innovation

Iowa Economic Mission Meets Jerusalem Biotech Leaders
Jerusalem, Israel – Sept. 11, 2017 – The Iowa Economic Development Authority mission, led by Iowa Governor Kim Reynolds, met with representatives of Jerusalem’s bio-medical

JLM based Entera Bio Raising $10m at $94m Valuation
Sept 13, 2017 – Entera is developing a drug for the treatment of osteoporosis. After announcing its general plan for a Nasdaq IPO, as well

BiondVax to Manufacture its Universal Flu Vaccine in Jerusalem!
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) signed a lease agreement for a commercial facility in Jerusalem to manufacture its universal flu vaccine. BiondVax Pharmaceuticals Ltd. also announced in

CellCure Invites the Public toJoin NeuroScience’s Clinical Trial To Treat Dry Age-Related Macular Degeneration
If you are over 50, and suffer from dry AMD (dry form, age-related macular degeneration), you may be eligible to join our clinical trial using

BrainsWay’s Backlog Revenues Due to Future Lease Agreements Increased 27% to $19 Million
Aug 22 2017 – Jerusalem based Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, announced the Company’s financial results for

New drug-testing technology from the Hebrew University could drastically cut animal testing
Aug 22 – Prof Yakov Nahmias’s human-on-a-chip platform has the unique ability to predict risk of toxicity in pharma and cosmetic product candidates without animal